Cargando…
Severe Hypercalcemia Due to Primary Hyperparathyroidism and Heterozygous Pathogenic Variant of CYP24A1
Pathogenic variants of CYP24A1 are associated with hypercalcemia due to disruptions in the ability of 24-hydroxylase to break down 1,25-dihydroxyvitamin D (1,25-DHVD). A case involving a heterozygous pathogenic variant of CYP24A1 and primary hyperparathyroidism leading to severe hypercalcemia has no...
Autores principales: | Liu, Jannel, Angelos, Peter, Barhoum, Maan, Jain, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578407/ https://www.ncbi.nlm.nih.gov/pubmed/37909006 http://dx.doi.org/10.1210/jcemcr/luad071 |
Ejemplares similares
-
THU472 Novel And Multifactorial Case Of Severe Hypercalcemia Due To Primary Hyperparathyroidism And Heterozygous Mutation Of CYP24A1
por: Liu, Jannel, et al.
Publicado: (2023) -
Correction to “Severe Hypercalcemia Due to Primary Hyperparathyroidism and Heterozygous Pathogenic Variant of CYP24A1”
Publicado: (2023) -
Diabetes due to recurrent pancreatitis secondary to hypercalcemia due to primary hyperparathyroidism
por: Chakrabarti, Sumit Kumar, et al.
Publicado: (2013) -
Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants
por: McBride, Lucy, et al.
Publicado: (2019) -
Case report: Two heterozygous pathogenic variants of CYP24A1: A novel cause of hypercalcemia and nephrocalcinosis in adulthood
por: Brunerova, Ludmila, et al.
Publicado: (2023)